NCT07169851 2026-03-06A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With CancerEli Lilly and CompanyPhase 2 Recruiting204 enrolled
NCT04305145 2026-01-29Infliximab for Treatment of Immune Checkpoint Inhibitor ColitisMassachusetts General HospitalPhase 2 Active not recruiting42 enrolled